Stockreport

Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster

ORION CORP NEW UNSP/ADR  (ORINY) 
PDF ORION CORPORATION INVESTOR NEWS 26 SEPTEMBER 2024 at 11.00 EEST         Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of d [Read more]